AGC Biologics Capacity Update October 2025: Large Molecule
Source: AGC Biologics
Michael Brotz provides an in-depth look at AGC Biologics' Seattle site, the unique capabilities of the facility, including its single-use and stainless-steel capacity, new manufacturing lines, and its expertise in supporting complex molecules. Explore the U.S. site's technical expertise, MSAT-driven process support, and how it flexibly meets client needs. Learn about the available capacity for 2026 and beyond.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma